약제 급여적정성 재평가 합리화 방안 연구
- Type
- Research report
- Issued Date
- 2023-03
- Publisher
- 건강보험심사평가원
- Table Of Contents
- 제1장 서론 ············································································· 1
1. 연구 배경 및 필요성 ··············································································· 3
2. 연구 목적 ······························································································ 4
3. 연구 내용 및 방법 ·················································································· 4
제2장 건강보험 급여 의약품의 사용 현황 분석 ············································································· 7
1. 최근 10년 등재 약제 제품 수 및 청구현황 분석 ······································ 9
2. 최근 10년 인구구조 변화에 따른 청구추세 분석 ······································ 22
제3장 약제 급여적정성 재평가 제도 분석 ············································································· 29
1. 약제 급여적정성 재평가 제도 고찰 ························································· 31
2. 약제 급여적정성 재평가 대상 성분 및 2007년 이후 최초 등재 성분
청구현황 분석 ······················································································ 57
제4장 외국의 약제 급여적정성 재평가 제도 운영 현황 ············································································· 78
1. 프랑스 ································································································· 80
2. 일본 ···································································································· 93
3. 호주 ·································································································· 109
제5장 이해관계자, 전문가 심층면접조사 ············································································· 116
1. 연구 개요 ·························································································· 118
2. 연구 방법 ·························································································· 118
3. 연구 결과 ·························································································· 123
4. 함의 ·································································································· 134
제6장 약제 급여적정성 재평가의 합리적 시행 방안 ············································································· 138
1. 약제 급여적정성 재평가의 시행 방향 ·················································· 140
2. 향후 약제 급여적정성 재평가 시행 방안 ··············································· 144
3. 약제 급여적정성 재평가의 합리적 운영 방안 ········································· 161
4. 약제 급여적정성 재평가의 사회적 영향 ················································· 163
◾ 참고 문헌 ····················································································· 166
- Publisher
- 건강보험심사평가원
- Location
- KOR
- Citation
- 박실비아. (2023-03). 약제 급여적정성 재평가 합리화 방안 연구.
- 파일 목록
-
-
Download
약제 급여적정성 재평가 합리화 방안 연구.pdf
기타 데이터 / 2.21 MB / Adobe PDF
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.